Back to Search
Start Over
Delivery of hepatocyte growth factor mRNA from nanofibrillar scaffolds in a pig model of peripheral arterial disease.
- Source :
-
Regenerative medicine [Regen Med] 2020 Jun; Vol. 15 (6), pp. 1761-1773. Date of Electronic Publication: 2020 Aug 10. - Publication Year :
- 2020
-
Abstract
- Background: Chemical modification of mRNA (mmRNA) substantially improves their stability and translational efficiency within cells. Nanofibrillar collagen scaffolds were previously shown to enable the spatially localized delivery and temporally controlled release of mmRNA encoding HGF both in vitro and in vivo . Materials & methods: Herein we developed an improved slow-releasing HGF mmRNA scaffold and tested its therapeutic efficacy in a porcine model of peripheral arterial disease. Results & conclusion: The HGF mmRNA was released from scaffolds in a temporally controlled fashion in vitro with preserved transfection activity. The mmRNA scaffolds improved vascular regeneration when sutured to the ligated porcine femoral artery. These studies validate the therapeutic potential of HGF mmRNA delivery from nanofibrillar scaffolds for treatment of peripheral arterial disease.
- Subjects :
- Animals
Collagen
Ischemia genetics
Ischemia pathology
Peripheral Arterial Disease genetics
Peripheral Arterial Disease pathology
RNA, Messenger genetics
Swine
Disease Models, Animal
Hepatocyte Growth Factor genetics
Hindlimb blood supply
Ischemia therapy
Peripheral Arterial Disease therapy
RNA, Messenger administration & dosage
Tissue Scaffolds chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1746-076X
- Volume :
- 15
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Regenerative medicine
- Publication Type :
- Academic Journal
- Accession number :
- 32772903
- Full Text :
- https://doi.org/10.2217/rme-2020-0023